109 related articles for article (PubMed ID: 11368382)
21. Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cells.
Nemunaitis J; Albo V; Zeigler ZR; Shadduck RK; Rosenfeld CS
Leuk Lymphoma; 1993 Jul; 10(4-5):405-6. PubMed ID: 8106066
[TBL] [Abstract][Full Text] [Related]
22. Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation.
Nakamura H; Nakao T; Ujiie H; Karasuno T; Teshima H; Komatsu K; Ishiguro S; Hiraoka A; Masaoka T
J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S457-61. PubMed ID: 10329849
[TBL] [Abstract][Full Text] [Related]
23. CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity.
Noga SJ; Vogelsang GB; Seber A; Davis JM; Schepers K; Hess AD; Jones RJ
Transplant Proc; 1997; 29(1-2):728-32. PubMed ID: 9123500
[No Abstract] [Full Text] [Related]
24. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM
N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic peripheral blood versus bone marrow transplantation: children are small adults and more.
Wall DA
J Clin Oncol; 2004 Dec; 22(24):4865-6. PubMed ID: 15520051
[No Abstract] [Full Text] [Related]
26. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer.
Appelbaum FR
CA Cancer J Clin; 1996; 46(3):142-64. PubMed ID: 8646545
[TBL] [Abstract][Full Text] [Related]
27. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection.
Zhang C; Zhang X; Chen XH
Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
Przepiorka D; Ippoliti C; Khouri I; Anderlini P; Mehra R; Giralt S; Gajewski J; Fritsche H; Deisseroth AB; Cleary K; Champlin R; van Besien K; Andersson B; Korbling M
Transplantation; 1996 Dec; 62(12):1806-10. PubMed ID: 8990368
[TBL] [Abstract][Full Text] [Related]
29. Ex Vivo CD34
Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
[TBL] [Abstract][Full Text] [Related]
30. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
31. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
[TBL] [Abstract][Full Text] [Related]
32. Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.
Tiberghien P; Hervé P
Transfus Sci; 1992; 13(4):443-54. PubMed ID: 10147740
[No Abstract] [Full Text] [Related]
33. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH
Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
[TBL] [Abstract][Full Text] [Related]
35. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
[TBL] [Abstract][Full Text] [Related]
36. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
37. Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.
Slavin S; Or R; Weiss L; Steiner-Zalz D; Cividalli G; Brautbar C; Weshler Z; Galun E; Samuels S; Galili D
Adv Exp Med Biol; 1985; 186():813-8. PubMed ID: 3901693
[No Abstract] [Full Text] [Related]
38. [Clinical application of bone marrow transplantation].
Lu DP
Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):75-7. PubMed ID: 8404327
[No Abstract] [Full Text] [Related]
39. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia].
Löwenberg B; Sizoo W; Wagemaker G; Sintnicolaas K; Hendriks WD; Hagenbeek A
Ned Tijdschr Geneeskd; 1986 May; 130(19):872-6. PubMed ID: 3520349
[No Abstract] [Full Text] [Related]
40. [Successful treatment of secondary graft failure in a mixed-phenotype acute leukemia patient with haploidentical hematopoietic stem cell transplantation and post-transplant cyclophosphamide administration].
Katayama O; Honda S; Yoshida N; Nagamatsu K; Takano K; Kawano R; Ogata M; Shirao K
Rinsho Ketsueki; 2018; 59(5):485-488. PubMed ID: 29877234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
